Hot sectors in a tepid recovery
The energy, finance, technology and healthcare industries are expected to be the hottest areas for dealmaking in 2010. Full Article | Full Coverage
TABLE-Valeant more than halves Q4 net loss
Feb 28 (Reuters) -
VALEANT PHARMACEUTICALS INTERNATIONAL INC. (VRX.N)
Latest Forecast* No. of Yr ago
analysts qtr Loss, (diluted, $/shr) 0.23 -- -- 0.48 EPS, pre ex#(dil, $/shr) 0.28 -- -- 0.18 Net loss ($ million) 21.8 -- -- 44.8 Revenue ($ million) 257.4 229.9 6 232.2
*Source: Reuters Estimates
#Excludes extraordinary, special or one-time items
--The pharmaceutical company said it recorded a charge of $5.2 million due to cost of goods sold in the 2006 fourth quarter for the transfer of manufacturing technology for Infergen.
--For the latest fourth quarter, analysts on average expected the company to earn 18 cents a share, excluding exceptional items, according to Reuters Estimates. (Reporting by Supantha Mukherjee in Bangalore)
